FP-253-GDEPT

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameFP-253-GDEPT
Drug Alias NameGDEPT (CSIRO)GDEPT (Mayne)OAdV gene therapy (Mayne)ovine adenovirus gene therapy (Mayne)PNP-GDEPT +[9] 
ClassificationBiologics
Mechanisms of ActionPurine nucleoside phosphorylase stimulants
TargetsPurine nucleoside phosphorylase
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMayne Pharma Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMayne Pharma Pty LtdCommonwealth Scientific And Industrial Research Organisation, AustraliaElk OrthoBiologics Ltd +[4] 
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A